Stock Analysts

NuStar Energy Beats Q4 Earnings on Record Throughput

NuStar Energy LP ( NS ), the San Antonio-based publicly traded partnership, reported strong fourth-quarter results backed by improved performances across its Pipeline and Storage segments. NuStar’s earnings per unit (EPU) from continuing operations came in at 55 cents, beating the Zacks Consensus Estimate of 53 cents. The bottom line also increased from the year-ago quarter figure of 21 cents per unit […]

Stock Analysts

Methanex’s (MEOH) Q4 Earnings Beat Estimates, Sales Miss

Methanex Corporation ( MEOH ) posted profits of $133 million in the fourth quarter of 2014, up 4% from $128 million reported a year ago. Earnings of $1.11 per share (treating stock-based compensation expense as a normal item) for the quarter beat the Zacks Consensus Estimates of 93 cents but were below $1.32 per share reported a year ago. In full-year 2014, the company’s adjusted earnings (excluding one-time items other than stock-based compensation expenses) came in at $4.38 per share, also surpassing the Zacks Consensus Estimates of $4.22 […]

Stock Analysts

Sysco’s (SYY) Q2 Earnings In Line, Provides Merger Update

Global food products maker and distributor Sysco Corporation ( SYY ) reported second quarter of fiscal 2015 results. Adjusted earnings of 41 cents matched the Zacks Consensus Estimate, and increased 5.1% year over year as an improvement in sales made up for the ongoing cost pressure. Sysco Corporation – Quarterly EPS | FindTheBest Quarter in Detail Sysco's sales grew 7.6% on a year over year basis to $12.087 billion in the second quarter of fiscal 2015, driven by 3.6% volume growth (including acquisitions). […]

Stock Analysts

Haemonetics Q3 Earnings Top Estimates, Drop Y/Y; Stock Up

Haemonetics Corporation ( HAE ) reported adjusted earnings of 53 cents per share in the third quarter of fiscal 2015, down a significant 13.1% year over year but a couple of cents ahead of the Zacks Consensus Estimate. On a reported basis, Haemonetics posted earnings per share of 31 cents, unchanged from the prior-year quarter. The year-over-year decline in the adjusted results is mainly attributable to a decline experienced in Haemonetics' whole blood business' pricing and volume, which outweighed the benefits that management gained from Value Creation and Capture ("VCC") as well as other cost-saving initiatives. […]

Stock Analysts

3 Best Performing Stocks in January

Markets experienced a difficult month with all benchmarks closing in the red. Global economic concerns and a continual slump in fuel prices emerged as the major headwinds for stocks. The political situation in Greece also weighed on investor sentiment. […]

Stock Analysts

Pitney Bowes Earnings In-Line on Digital Commerce Business

Pitney Bowes Inc. ( PBI ) reported fourth-quarter 2014 adjusted earnings per share from continuing operations of 51 cents, which came in line with both the Zacks Consensus Estimate as well as the year-ago quarter figure. Profits during the quarter were driven by strength in the Digital Commerce Solution business. […]